Ming Q. Shi

651 Dongfeng East Road
Guangzhou, 510060, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 191 publications

Application of aptamer nucleic acid test strips in the detection of tumor markers for colorectal cancer.

Application of aptamer nucleic acid test strips in the detection of tumor markers for colorectal cancer.

Journal: The Analyst

Published: August 30, 2026

Transarterial Chemoembolization Plus Thermal Ablation in Unresectable Hepatocellular Carcinoma: The Phase 3 TORCH Randomized Clinical Trial.

Transarterial Chemoembolization Plus Thermal Ablation in Unresectable Hepatocellular Carcinoma: The Phase 3 TORCH Randomized Clinical Trial.

Journal: JAMA oncology

Published: July 30, 2026

Hepatic Arterial Infusion Chemotherapy Plus Systemic Chemotherapy, Lenvatinib and PD-(L)1 Inhibitors Versus Systemic Chemotherapy Plus PD-(L)1 Inhibitors in Advanced Intrahepatic Cholangiocarcinoma.

Hepatic Arterial Infusion Chemotherapy Plus Systemic Chemotherapy, Lenvatinib and PD-(L)1 Inhibitors Versus Systemic Chemotherapy Plus PD-(L)1 Inhibitors in Advanced Intrahepatic Cholangiocarcinoma.

Journal: Technology in cancer research & treatment

Published: April 29, 2026

Genome-Scale CRISPR Screens Reveal DNA Repair Dependencies That Sensitize Hepatocellular Carcinoma to Oxaliplatin.

Genome-Scale CRISPR Screens Reveal DNA Repair Dependencies That Sensitize Hepatocellular Carcinoma to Oxaliplatin.

Journal: Cancers

Published: February 14, 2026

Targeting Dnmt3a/m5C/RelA Axis Attenuates Microglia Inflammatory Response and Improves Postoperative Recovery in Chronic Compressive Cervical Spinal Cord Injury.

Targeting Dnmt3a/m5C/RelA Axis Attenuates Microglia Inflammatory Response and Improves Postoperative Recovery in Chronic Compressive Cervical Spinal Cord Injury.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: February 05, 2026

Engineering a DNA logic-gated theranostic multi-antisense oligonucleotide nanoactivator for cell subtype-specific molecular therapy.

Engineering a DNA logic-gated theranostic multi-antisense oligonucleotide nanoactivator for cell subtype-specific molecular therapy.

Journal: International journal of biological macromolecules

Published: January 14, 2026

Hepatic Arterial Infusion Chemotherapy plus either Toripalimab or Sorafenib as First-line Therapy for Locally Advanced Hepatocellular Carcinoma: A Non-comparative, Randomized Phase 2 Trial.

Hepatic Arterial Infusion Chemotherapy plus either Toripalimab or Sorafenib as First-line Therapy for Locally Advanced Hepatocellular Carcinoma: A Non-comparative, Randomized Phase 2 Trial.

Journal: MedComm

Published: January 06, 2026

An integrative genetic and transcriptomic study reveals a causal link and candidate biomarkers between tuberculosis and asthma.

An integrative genetic and transcriptomic study reveals a causal link and candidate biomarkers between tuberculosis and asthma.

Journal: Frontiers in genetics

Published: December 17, 2025

Simulated construction of tilmicosin nucleic acid aptamers based on molecular docking and molecular dynamics techniques.

Simulated construction of tilmicosin nucleic acid aptamers based on molecular docking and molecular dynamics techniques.

Journal: Analytica chimica acta

Published: December 15, 2025

Fluid-Derived Organoids from Pleural Effusion and Ascites: Emerging Models for Drug Resistance and Personalized Oncology.

Fluid-Derived Organoids from Pleural Effusion and Ascites: Emerging Models for Drug Resistance and Personalized Oncology.

Journal: Journal of Cancer

Published: October 29, 2025

Research on the Effect of NK Cells Based on Functionalized Magnetic Beads on Cervical Cancer Mice.

Research on the Effect of NK Cells Based on Functionalized Magnetic Beads on Cervical Cancer Mice.

Journal: ACS applied bio materials

Published: October 03, 2025

Sorafenib plus hepatic arterial infusion chemotherapy versus sorafenib plus transarterial chemoembolization in advanced hepatocellular carcinoma: a phase III trial and biomarker analyses.

Sorafenib plus hepatic arterial infusion chemotherapy versus sorafenib plus transarterial chemoembolization in advanced hepatocellular carcinoma: a phase III trial and biomarker analyses.

Journal: Journal of the National Cancer Center

Published: September 09, 2025

Showing 1-12 of 191

Last Updated: 09/26/2026